Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Clinical trials sponsored by Chia Tai Tianqing Pharmaceutical Group Co., Ltd., explained in plain language.
-
New pill combo shows promise against tough breast cancer
Disease control CompletedThis study tested a new drug (TQB3616) combined with a standard hormone therapy (fulvestrant) in 122 people with advanced HR-positive, HER2-negative breast cancer. The goal was to see if the combination could shrink tumors or delay cancer growth. Participants had either received …
Phase: PHASE2 • Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd. • Aim: Disease control
Last updated Apr 28, 2026 13:02 UTC
-
New hope for Hard-to-Treat thyroid cancer: AL2846 shows promise in early trial
Disease control CompletedThis study tested a new drug called AL2846 in 33 adults with a type of thyroid cancer that no longer responds to radioactive iodine or standard targeted therapies. The goal was to see if the drug could shrink tumors or slow cancer growth. Participants took the capsule daily, and …
Phase: PHASE1, PHASE2 • Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd. • Aim: Disease control
Last updated Apr 26, 2026 20:00 UTC